Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Solid pseudopapillary neoplasm of the pancreas: Clinical-pathological features and management, a single-center experience

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Function, information, and contributions: An evaluation of national multidisciplinary team meetings for rare cancers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Anal Cancer debuting as Cancer of Unknown Primary

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pitfalls of histopathological evaluation of EUS guided microbiopsies from pancreatic cystic neoplasms

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Solid pseudopapillary neoplasm of the pancreas is a rare tumor of low malignancy that occurs most often in females. The study describes the clinicopathologic characteristics of the tumor and common differential diagnoses. Data were collected from a prospectively maintained database. Of 1661 patients operated for pancreatic tumors between January 2001 and September 2018, 15 patients were recorded. Patients included 12 females and 3 males, median age 40 (range 10 -87) years. Computed tomography or magnetic resonance imaging was diagnostic in eight patients and a preoperative biopsy in eight out of 10 patients. Median tumor size was 5 cm (range 2 -16 cm), 12 tumors were in the head, six in the body, and three in the tail of the gland. All patients except one had radical resection including one with hepatic and lymph node metastases, no patient underwent oncologic treatment. All patients are alive from 17.5 to 209.4 months postoperatively and without recurrence. Radical operation is usually curative and should also be offered to patients with metastases or recurrence as oncologic treatment has limited effect.

OriginalsprogEngelsk
TidsskriftRare Tumors
Vol/bind11
Sider (fra-til)E 2036361319878513
ISSN2036-3605
DOI
StatusUdgivet - 2019

Bibliografisk note

© The Author(s) 2019.

ID: 58458197